v3.25.4
NET INCOME PER SHARE (Tables)
 6 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of net income per share for the periods presented:
Three Months Ended December 31,Six Months Ended December 31,
(in thousands, except per share amounts)
2025202420252024
Numerator:
Net income attributable to common shareholders, basic$51,168 $53,236 $3,227 $8,690 
Change in fair value of warrants(1)
(1,112)— (1,962)— 
Net income attributable to common shareholders, diluted50,056 53,236 1,265 8,690 
Denominator:
Weighted-average common stock outstanding, basic187,573 171,802 186,694 171,116 
Stock options outstanding to purchase shares of common stock including unvested RSUs and from the ESPP1,247 3,299 2,024 3,908 
Dilutive effect of warrants to purchase common stock2,010 — 2,012 — 
Weighted-average common stock outstanding, diluted
190,830 175,101 190,730 175,024 
Net income per share—basic:$0.27 $0.31 $0.02 $0.05 
Net income per share—diluted:$0.26 $0.30 $0.01 $0.05 
(1) Includes the change in fair value of warrant liabilities to the extent the related warrants to purchase common stock are dilutive or the effect is not anti-dilutive.
Schedule of Antidilutive Securities Excluded from Computation of Income (Loss) Per Share
The weighted average potential shares of common stock that were excluded from the calculation of net income per share-diluted for the periods presented because including them would have been anti-dilutive consisted of the following:
Three Months Ended December 31,Six Months Ended December 31,
(in thousands)2025202420252024
Stock options outstanding to purchase shares of common stock, unvested RSUs and shares from the ESPP
5,357 4,875 4,850 4,164 

The weighted average potential shares of common stock that were excluded from the calculation of net income per share-diluted because the performance or market conditions associated with these awards were not met are as follows for the periods presented:
Three Months Ended December 31,Six Months Ended December 31,
(in thousands)2025202420252024
Shares subject to outstanding PVUs
8,412 8,151 8,526 7,393 

The weighted average potential shares of common stock that were excluded from the calculation of net income per share-diluted because the exercise price of the warrants exceeded the average market price of the Company's common stock or the effect would have been anti-dilutive for the periods presented:
Three Months Ended December 31,Six Months Ended December 31,
(in thousands)2025202420252024
Warrants to purchase shares of common stock22,920 5,568 22,920 5,568